Patents by Inventor Paul M. Moran

Paul M. Moran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190016826
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: September 26, 2018
    Publication date: January 17, 2019
    Inventors: Yan Wu, Menno van Lookeren Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, JR., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • Publication number: 20170342163
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 30, 2017
    Inventors: Yan WU, Menno van LOOKEREN CAMPAGNE, Daniel KIRCHHOFER, Michael Terry LIPARI, Kenneth J. KATSCHKE, Jr., Paul M. MORAN, Scott STAWICKI, Wei-Ching LIANG
  • Patent number: 9738727
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: August 22, 2017
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Menno van Lookeren-Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, Jr., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • Patent number: 8435511
    Abstract: The invention provides hepsin antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: May 7, 2013
    Assignee: Genentech, Inc.
    Inventors: Rajkumar Ganesan, Daniel Kirchhofer, Paul M. Moran, Yingnan Zhang
  • Publication number: 20130022611
    Abstract: The invention provides methods and compositions for modulating hepsin activity and the uPA/plasmin pathway, in particular by regulating pro-uPA activation by hepsin.
    Type: Application
    Filed: May 25, 2012
    Publication date: January 24, 2013
    Applicant: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Paul M. Moran
  • Publication number: 20110262452
    Abstract: The invention provides hepsin antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: October 21, 2010
    Publication date: October 27, 2011
    Applicant: Genentech, Inc.
    Inventors: Rajkumar Ganesan, Daniel Kirchhofer, Paul M. Moran, Yingnan Zhang
  • Publication number: 20100209956
    Abstract: The invention provides methods and compositions for modulating hepsin activity and the HGF/c-met signaling pathway, in particular by regulating pro-HGF activation by hepsin.
    Type: Application
    Filed: March 10, 2010
    Publication date: August 19, 2010
    Applicant: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Paul M. Moran, Mark D. Peek
  • Publication number: 20100061996
    Abstract: The invention provides methods and compositions for modulating hepsin activity and the uPA/plasmin pathway, in particular by regulating pro-uPA activation by hepsin.
    Type: Application
    Filed: June 20, 2007
    Publication date: March 11, 2010
    Applicant: GENENTECH, INC.
    Inventors: Daniel K. Kirchhofer, Paul M. Moran
  • Publication number: 20090075317
    Abstract: The invention provides methods and compositions for modulating hepsin activity and the HGF/c-met signaling pathway, in particular by regulating pro-HGF activation by hepsin.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 19, 2009
    Applicant: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Paul M. Moran, Mark D. Peek
  • Patent number: 7432044
    Abstract: The invention provides methods and compositions for modulating hepsin activity and the HGF/c-met signaling pathway, in particular by regulating pro-HGF activation by hepsin.
    Type: Grant
    Filed: July 25, 2005
    Date of Patent: October 7, 2008
    Assignee: Genentech, Inc.
    Inventors: Daniel K. Kirchhofer, Paul M. Moran, Mark D. Peek
  • Patent number: 5106739
    Abstract: Unexpectedly high levels of expression of coding sequences can be obtained by the use of a CaMv 35s enhanced mannopine synthase promoter in plant host cells.
    Type: Grant
    Filed: February 7, 1990
    Date of Patent: April 21, 1992
    Assignee: Calgene, Inc.
    Inventors: Luca Comai, Paul M. Moran
  • Patent number: 5095205
    Abstract: A spectroanalytical system with a plurality of radiation sources and structure defining an analysis region that includes means for thermally energizing a sample material to be analyzed. Analysis beam path defining structure includes means for passing a radiation beam from a radiation source along the analysis beam path through the analysis region for modification by sample material in the analysis region. Analysis structure includes radiation dispersing structure arranged to disperse radiation in the analysis beam path with a spectrum and a radiation sensor. First transducer structure moves the dispersing structure relative to the beam path to apply a selected portion of the radiation dispersed by the dispersing structure to the radiation sensor.
    Type: Grant
    Filed: March 1, 1991
    Date of Patent: March 10, 1992
    Assignee: Thermo Jarrell Ash Corporation
    Inventors: Robert G. Schleicher, Bruce C. Fitz-Patrick, Paul M. Moran, David L. Pfeil